Brief Articles
Copyright ©2009 The WJG Press and Baishideng.
World J Gastroenterol. Jul 28, 2009; 15(28): 3504-3510
Published online Jul 28, 2009. doi: 10.3748/wjg.15.3504
Table 2 Clinical factors associated with behavior change from inflammatory to complicated disease behavior n (%)
FactorPrevalence without behavior changePrevalence with behavior changeP-valueOR95% CI
Disease location
L119 (13.9)17 (27.9)
L255 (40.1)18 (29.5)0.04--
L363 (46)25 (41)
L40 1 (1.6)
Perianal disease30 (22.2)30 (49.2)< 0.0013.41.78-6.46
Frequent relapses18 (13.1)19 (31.1)0.0033.01.43-6.23
Disease duration (> 10 yr)28 (20.4)35 (57.4)< 0.0015.32.7-10.1
Smoking51 (37.2)32 (52.5)0.041.91.02-3.45
Steroid use106 (77.4)59 (96.7)0.0018.62.00-37.3
Early azathioprine use79 (57.7)24 (39.3)0.0170.480.26-0.88
Early azathioprine/biological use83 (60.6)25 (41)0.010.450.24-0.84
Need for operation19 (13.9)37 (60.7)< 0.0019.64.72-19.4

  • Citation: Lakatos PL, Czegledi Z, Szamosi T, Banai J, David G, Zsigmond F, Pandur T, Erdelyi Z, Gemela O, Papp J, Lakatos L. Perianal disease, small bowel disease, smoking, prior steroid or early azathioprine/biological therapy are predictors of disease behavior change in patients with Crohn’s disease. World J Gastroenterol 2009; 15(28): 3504-3510
  • URL: https://www.wjgnet.com/1007-9327/full/v15/i28/3504.htm
  • DOI: https://dx.doi.org/10.3748/wjg.15.3504